Exploring Variation in the Use of Conservative Management for Prostate Cancer in the Veterans Affairs Healthcare System
Loeb S, Byrne NK, Wang B, Makarov DV, Becker D, Wise DR, Lepor H, Walter D.
“Exploring Variation in the Use of Conservative Management for Prostate Cancer in the Veterans Affairs Healthcare System.”
European Urology. 2020 Feb 22:S0302-2838(20)30101-9. PMID: 32098730.
Link: https://pubmed.ncbi.nlm.nih.gov/32098730/
Concordance and Performance of 4KScore and SelectMDx for Informing Decision to Perform Prostate Biopsy and Detection of Prostate Cancer
Wysock JS, Becher E, Persily J, Loeb S, Lepor H.
“Concordance and Performance of 4KScore and SelectMDx for Informing Decision to Perform Prostate Biopsy and Detection of Prostate Cancer.”
Urology. 2020 Apr 12:S0090-4295(20)30339-3. PMID: 32294481
Link: https://pubmed.ncbi.nlm.nih.gov/32294481/
The Association of Veterans PSA Screening Rates with Changes in USPSTF Recommendations
Becker DJ, Rude T, Walter D, Wang C, Loeb S, Li H, Ciprut S, Kelly M, Zeliadt SB, Fagerlin A, Lepor H, Sherman S, Ravenell JE, Makarov DV.
“The Association of Veterans’ PSA Screening Rates with Changes in USPSTF Recommendations.”
J Natl Cancer Inst. 2020 Aug 14:djaa120. PMID: 32797212
Link: https://pubmed.ncbi.nlm.nih.gov/32797212/
Prostate Cancer. Nature Reviews Disease Primers
Rebello RJ, Oing C, Knudsen KE, Loeb S, Johnson DC, Reiter RE, Gillessen S, Van der Kwast T, Bristow RG.
“Prostate Cancer. Nature Reviews Disease Primers.”
2021 Feb 4;7(1):9. PMID: 33542230.
Link: https://pubmed.ncbi.nlm.nih.gov/33542230/
Clinical Implications of Germline Testing in Newly Diagnosed Prostate Cancer
Loeb S. and Giri VN.
“Clinical Implications of Germline Testing in Newly Diagnosed Prostate Cancer.”
Eur Urol Oncol. 2021 Feb;4(1):1-9. Epub 2020 Dec 31. PMID: 33390340
Link: https://pubmed.ncbi.nlm.nih.gov/33390340/
Prostate Cancer. Nature Reviews Disease Primers
Rebello RJ, Oing C, Knudsen KE, Loeb S, Johnson DC, Reiter RE, Gillessen S, Van der Kwast T, Bristow RG.
“Prostate Cancer. Nature Reviews Disease Primers.”
2021 Feb 4;7(1):9. PMID: 33542230
Link: https://pubmed.ncbi.nlm.nih.gov/33542230/
Untitled
Butler SS, Loeb S, Cole AP, Zaslowe-Dude C, Muralidhar V, Kim DW, Schaeffer EM, Trinh QD, Nguyen PL, Mahal BA.
“United States trends in active surveillance or watchful waiting across patient socioeconomic status from 2010 to 2015. Prostate Cancer Prostatic Dis.”
2019 Oct 7 epub. PMID: 31591454.
Link: https://www.ncbi.nlm.nih.gov/pubmed/31591454
Untitled
Fine ND, LaPolla F, Epstein M, Loeb S, Dani H.
” Genomic Classifiers for Treatment Selection in Newly Diagnosed Prostate Cancer.”
BJU International 2019 May epub. PMID:31055874.
Link: https://www.ncbi.nlm.nih.gov/pubmed/31055874
Untitled
Loeb S, Folkvaljon Y, Bratt O, Robinson D, Stattin P.
“Defining Intermediate-Risk Prostate Cancer Suitable for Active Surveillance.”
Journal of Urology. 2018 Sep 18 epub. PMID: 30240688.
Link: https://www.ncbi.nlm.nih.gov/pubmed/30240688
Untitled
Loeb S, Curnyn C, Walter D, Fagerlin A, Siebert U, Mühlberger N, Braithwaite RS, Schwartz MD, Lepor H, Sedlander E.
“Health state utilities among contemporary prostate cancer patients on active surveillance.”
Translational Andrology and Urology. 2018 Apr; 7(2):197-202. PMID: 29732277.
Link: https://www.ncbi.nlm.nih.gov/pubmed/29732277
Punnen S, Freedland SJ, Polascik TJ, Loeb S, Risk MC, Savage S, Mathur SC, Uchio E, Dong Y, Silberstein JL.
” A Multi-institutional Prospective Trial in the Veterans Affairs Health System confirms the 4Kscore maintains its Predictive value among African American Men.”
Journal of Urology 2017, epub Dec 6. PMID: 29223389
Link: https://www.ncbi.nlm.nih.gov/pubmed/29223389
Spratt DE, Zhang J, Santiago-Jiménez M, Dess RT, Davis JW, Den RB, Dicker AP, Kane CJ, Pollack A, Stoyanova R, Abdollah F, Ross AE, Cole A, Uchio E, Randall JM, Nguyen H, Zhao SG, Mehra R, Glass AG, Lam LLC, Chelliserry J, du Plessis M, Choeurng V, Aranes M, Kolisnik T, Margrave J, Alter J, Jordan J, Buerki C, Yousefi K, Haddad Z, Davicioni E, Trabulsi EJ, Loeb S, Tewari A, Carroll PR, Weinmann S, Schaeffer EM, Klein EA, Karnes RJ, Feng FY, Nguyen PL
” Development and Validation of a Novel Integrated Clinical-Genomic Risk Group Classification for Localized Prostate Cancer.”
Journal of Clinical Oncology. 2017 Nov 29 epub. PMID: 29185869.
Link: https://www.ncbi.nlm.nih.gov/pubmed/29185869
Loeb S, Curnyn C, Fagerlin A, Braithwaite RS, Schwartz MD, Lepor H, Carter HB, Sedlander E.
“Informational needs during active surveillance for prostate cancer: A qualitative study.”
Patient Education Counseling 2017 Sep 1 epub. PMID: 28886974
Link: https://www.ncbi.nlm.nih.gov/pubmed/28886974
Loeb S, Folkvaljon Y, Damber JE, Alukal J, Lambe M, Stattin P.
“Testosterone Replacement Therapy and Risk of Favorable and Aggressive Prostate Cancer.”
Journal of Clinical Oncology 2017;35(13):1430-1436. PMID: 28447913.
Link: https://www.ncbi.nlm.nih.gov/pubmed/28447913
Loeb S, Curnyn C, Fagerlin A, Braithwaite RS, Schwartz MD, Lepor H, Carter HB, Sedlander E.
“A Qualitative Study on Decision-Making by Prostate Cancer Physicians during Active Surveillance.”
BJU International. 2016 epub. PMID: 27611479.
Link: https://www.ncbi.nlm.nih.gov/pubmed/27611479
Loeb S, Shin SS, Broyles DL, Wei JT, Sanda M, Klee G, Partin AW, Sokoll L, Chan DW, Bangma CH, van Schaik RH, Slawin KM, Marks LS, Catalona WJ.
“Prostate Health Index improves multivariable risk prediction of aggressive prostate cancer”
BJU International. 2016 Oct 15. PMID:27743489
Link: https://www.ncbi.nlm.nih.gov/pubmed/27743489
Crawford ED, Rosenberg MT, Partin AW, Cooperberg MR, Maccini M, Loeb S, Pettaway CA, Shore ND, Arangua P, Hoenemeyer J, Leveridge M, Leapman M, Pinto P, Thompson IM Jr, Carroll P, Eastham J, Gomella L, Klein EA.
“An Approach Using PSA Levels of 1.5 ng/mL as the Cutoff for Prostate Cancer Screening in Primary Care.”
Urology. 2016 Jul 19 epub. PMID: 27450937.
Link: https://www.ncbi.nlm.nih.gov/pubmed/27450937
Loeb S, Folkvaljon Y, Robinson D, Makarov DV, Bratt O, Garmo H, and Stattin P.
“Immediate versus delayed prostatectomy: Nationwide population-based study.”
Scandinavian Journal of Urology 2016 Apr 12 epub. PMID: 27067998.
Link: http://www.ncbi.nlm.nih.gov/pubmed/27067998
Sotelo R, Mora K. E, Perez L. H, Novoa J, Castillo M, Carmona O, De Andrade R, Loeb S, and Catalona WJ.
“Assay Standardization Bias: Different Prostate Cancer Detection Rates and Clinical Outcomes Resulting From Different Assays for Free and Total Prostate-Specific Antigen (PSA).”
Urology, June 2007; 69: 1143.
Link: http://www.ncbi.nlm.nih.gov/pubmed/17572203
Loeb S.
“Guideline of guidelines: prostate cancer screening.”
BJU International 2014 September; 114: 323.
PMID: 24981126.
Link: http://www.ncbi.nlm.nih.gov/pubmed/23567643
Knowledge and practice regarding prostate cancer germline testing among urologists: Gaps to address for optimal implementation.
Loeb S, Byrne N, Walter D, Makarov DV, Wise DR, Becker D, Giri VN.
“Knowledge and practice regarding prostate cancer germline testing among urologists: Gaps to address for optimal implementation.”
Cancer Treat Res Commun. 2020 Sep 28;25:100212. PMID: 33091732
Link: https://pubmed.ncbi.nlm.nih.gov/33091732/
Loeb S, Helfand BT, Kan D, Isaacs WB, and Catalona WJ.
“Does Diabetes Mellitus Modify the Association between 17q12 Risk Variant and Prostate Cancer Aggressiveness?”
BJU International, November 2009; 104: 1200.
Link: http://www.ncbi.nlm.nih.gov/pubmed/19627283
Helfand BT, Loeb S, Kan D, Catalona WJ.
“Number of prostate cancer risk alleles may identify possibly ‘insignificant’ disease.”
BJU International, June 2010 epub.
Link: http://www.ncbi.nlm.nih.gov/pubmed/20590552
Helfand BT, Fought AJ, Loeb S, Meeks JJ, Kan D, and Catalona WJ.
“Genetic prostate cancer risk assessment: common variants in 9 genomic regions are associated with cumulative risk.”
Journal of Urology, August 2010; 184: 501.
Link: http://www.ncbi.nlm.nih.gov/pubmed/20620408
Cooper PR, McGuire BB, Helfand BT, Loeb S, Hu Q, and Catalona WJ.
“Prostate Cancer Risk Alleles and Their Associations with Other Malignancies.”
Urology October 2011; 78: 970 .e 15-20.
PMID: 21820706.
Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3190015/
Helfand BT, Hu Q, Loeb S, McVary KT, Catalona WJ.
“Genetic Sequence Variants are Associated with Severity of Lower Urinary Tract Symptoms and Prostate Cancer Susceptibility.”
Journal of Uroloy 2012 epub November.
PMID: 23159463.
Link: http://www.ncbi.nlm.nih.gov/pubmed/23159463
Reinhardt D, Helfand BT, Cooper PR, Roehl KA, Catalona WJ, and Loeb S.
“Prostate Cancer Risk Alleles are Associated with Prostate Cancer Tumor Volume and Prostate Size.”
Journal of Urology 2013; epub Dec 14.
PMID: 24345439
Link: http://www.ncbi.nlm.nih.gov/pubmed/24345439
Grin B, Loeb S, Roehl K, Cooper PR, Catalona WJ, Helfand BT.
“A rare 8q24 single nucleotide polymorphism (SNP) predisposes North American men to prostate cancer and possibly more aggressive disease.”
BJU International 2014, June epub.
PMID: 24952954.
Link: http://www.ncbi.nlm.nih.gov/pubmed/24952954
Loeb S, Peskoe SB, Joshu CE, Huang WY, Hayes RB, Carter HB, Isaacs WB, Platz EA
“Do Environmental Factors Modify the Genetic Risk of Prostate Cancer?”
Cancer Epidemiology Biomarkers Prevention 2015; 24: 213. PMID: 25342390.
Link: http://www.ncbi.nlm.nih.gov/pubmed/25342390
Bostrӧm PJ, Bjartell AS, Catto JW, Eggener SE, Lilja H, Loeb S, Schalken J, Schlomm T, and Cooperberg MR.
“Genomic Predictors of Outcome in Prostate Cancer.”
European Urology 2015 epub. PMID: 25913390.
Link: http://www.ncbi.nlm.nih.gov/pubmed/25913390
Borghesi M, Ahmed H, Nam R, Schaeffer E, Schiavina R, Taneja S, Weidner W, Loeb S.
“Complications After Systematic, Random, and Image-guided Prostate Biopsy.”
European Urology. 2016 Aug 16 epub. PMID: 27543165.
Link: https://www.ncbi.nlm.nih.gov/pubmed/27543165
Loeb S, Curnyn C, Sedlander E.
“Perspectives of Prostate Cancer Patients on Gleason Scores and the New Grade Groups: Initial Qualitative Study.”
European Urology 2016 Jun 6 epub. PMID: 27283215.
Link: http://www.ncbi.nlm.nih.gov/pubmed/27283215
Loeb S, Walter D, Curnyn C, Gold HT, Lepor H, Makarov DV.
“How Active is Active Surveillance? Intensity of Follow-Up During Active Surveillance for Prostate Cancer in the United States.”
Journal of Urology 2016 Mar 2 epub. PMID: 26946161.
Link: http://www.ncbi.nlm.nih.gov/pubmed/26946161
Other Original Articles
Thomsen FB, Folkvaljon Y, Garmo H, Robinson D, Loeb S, Ingvar C, Lambe M, Stattin P.
“Risk of malignant melanoma in men with prostate cancer. Nationwide, population-based cohort study.”
International Journal of Cancer. 2015 Dec 14 epub. PMID: 26662367
Link: http://www.ncbi.nlm.nih.gov/pubmed/26662367
Other Original Articles
Bostrӧm PJ, Bjartell AS, Catto JW, Eggener SE, Lilja H, Loeb S, Schalken J, Schlomm T, and Cooperberg MR.
“Genomic Predictors of Outcome in Prostate Cancer.”
European Urology 2015 epub. PMID: 25913390.
Link: http://www.ncbi.nlm.nih.gov/pubmed/25913390
Other Original Articles
Loeb S, Bruinsma SM, Nicholson J, Briganti A, Pickles T, Kakehi Y, Carlsson SV, Roobol MJ.
“Active Surveillance for Prostate Cancer: A Systematic Review of Clinicopathologic Variables and Biomarkers for Risk Stratification.”
European Urology 2014 Oct epub. PMID: 25457014
Link: http://www.ncbi.nlm.nih.gov/pubmed/25457014
Other Original Articles
Loeb S, Sokoll LJ, Broyles DL, Bangma CH, van Schaik RH, Klee GG, Wei JT, Sanda MG, Partin AW, Slawin KM, Marks LS, Mizrahi IA, Shin SS, Cruz AB, Chan DW, Roberts WL, Catalona WJ.
“Prospective Multicenter Evaluation of the Beckman Coulter Prostate Health Index Using WHO Calibration.”
Journal of Urology 2012; epub November. PMID: 23206426.
Link: http://www.ncbi.nlm.nih.gov/pubmed/23206426
Other Original Articles
Tosoian JJ, Loeb S, Feng Z, Isharwal S, Landis P, Elliot DJ, Veltri R, Epstein JI, Partin AW, Carter HB, Trock B, Sokoll LJ.
“Association of [-2]proPSA with Biopsy Reclassification During Active Surveillance for Prostate Cancer.”
Journal of Urology 2012; 188: 1131-6. PMID: 22901577.
Link: http://www.ncbi.nlm.nih.gov/pubmed/22901577
Other Original Articles
Nichols JH, Loeb S, Metter EJ, Ferrucci L, Carter HB.
“The Relationship Between Prostate Volume and Prostate-Specific Antigen Variability: Data from the Baltimore Longitudinal Study of Aging and the Johns Hopkins Active Surveillance Program.”
BJU International 2012; 109: 1304-8. PMID: 22093443.
Link: http://www.ncbi.nlm.nih.gov/pubmed/22093443
Other Original Articles
Roobol MJ, van Vugt HA, Loeb S, Zhu X, Bul M, Bangma CH, van Leenders AG, Steyerberg EW, and Schroder FH.
“Prediction of Prostate Cancer Risk: The Role of Prostate Volume and Digital Rectal Examination in the ERSPC Risk Calculators.”
European Urology 2012; 61: 577-83. PMID: 22104592.
Link: http://www.ncbi.nlm.nih.gov/pubmed/22104592
Other Original Papers
Thaxton CS, Loeb S, Roehl KA, Kan D, and Catalona WJ.
“Treatment Outcomes of Radical Prostatectomy in Potential Candidates for 3 Published Active Surveillance Programs.”
Urology, February 2010; 75: 414.
Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072831/
Other Original Articles
Makarov DV, Loeb S, Magheli A, Zhao K, Humphreys E, Gonzalgo ML, Partin AW, and Han M.
“Significance of Preoperative PSA Velocity in Men with Low Serum PSA and Normal DRE.”
World Journal of Urology 2011; 29: 11.
Link: http://www.ncbi.nlm.nih.gov/pubmed/21153643
Other Original Articles
Loeb S, Carter HB, Schaeffer EM, Kettermann A, Ferrucci L, and Metter EJ.
“Distribution of PSA Velocity by Total PSA Levels: Data from the Baltimore Longitudinal Study of Aging.”
Urology January 2011; 77: 143.
Link: http://www.ncbi.nlm.nih.gov/pubmed/21195835
Other Original Articles
Le BV, Griffin CR, Loeb S, Carvalhal GF, Kan D, Baumann NA, and Catalona WJ.
“[-2] Proenzyme prostate specific antigen is more accurate than total and free prostate specific antigen in differentiating prostate cancer from benign disease in a prospective prostate cancer screening study.”
Journal of Urology 2010; 183: 1355.
Link: http://www.ncbi.nlm.nih.gov/pubmed/20171670
Other Original Articles
Tosoian JJ, Loeb S, Kettermann A, Landis P, Elliot DJ, Epstein JI, Partin AW, Carter HB, and Sokoll LJ.
“Accuracy of PCA3 Measurement in Predicting Short-Term Biopsy Progression in an Active Surveillance Program.”
Journal of Urology, February 2010; 183: 534.
Link: http://www.ncbi.nlm.nih.gov/pubmed/20006883
Other Original Articles
Kettermann AE, Ferrucci L, Trock BJ, Metter EJ, Loeb S and Carter HB.
“Interpretation of the prostate-specific antigen history in assessing life-threatening prostate cancer.”
BJU International 2010 epub.
Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2928882/
Other Original Articles
Loeb S, Kan D, Yu X, Roehl KA, and Catalona WJ.
“Preoperative Prostate Specific Antigen Doubling Time is Not a Useful Predictor of Biochemical Progression After Radical Prostatectomy.”
Journal of Urology, May 2010; 183: 1816.
Link: http://www.ncbi.nlm.nih.gov/pubmed/20303104
Other Original Articles
Loeb S, Roehl KA, Helfand BT, Kan D, and Catalona WJ.
“Can PSA Velocity Thresholds Reduce the Detection of Insignificant Prostate Cancer?”
Journal of Urology 2010; 183: 112.
Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3140466/
Other Original Articles
Loeb S, Kettermann A, Carter HB, Metter EJ, Ferrucci L, and Walsh PC.
“Prostate Volume Changes Over Time: Results From the Baltimore Longitudinal Study of Aging.”
Journal of Urology 2009 epub.
Link: http://www.ncbi.nlm.nih.gov/pubmed/19683305
Other Original Articles
Loeb S.
“Guideline of guidelines: prostate cancer screening.”
BJU International 2014 September; 114: 323. PMID: 24981126.
Link: http://www.ncbi.nlm.nih.gov/pubmed/23567643
Other Original Articles
Loeb S, Sutherland DE, D’Amico AV, Roehl KA, and Catalona WJ.
“PSA Velocity is Associated with Gleason Score in Radical Prostatectomy Specimen: Marker for Prostate Cancer Aggressiveness.”
Urology, June 2008 (epub).
Link: http://www.ncbi.nlm.nih.gov/pubmed/18571700
Other Original Articles
Bostrӧm PJ, Bjartell AS, Catto JW, Eggener SE, Lilja H, Loeb S, Schalken J, Schlomm T, and Cooperberg MR.
“Genomic Predictors of Outcome in Prostate Cancer.”
European Urology 2015 epub. PMID: 25913390.
Link: http://www.ncbi.nlm.nih.gov/pubmed/25913390
Other Original Articles
Loeb S, Kettermann A, Ferrucci L, Landis P, Metter EJ, and Carter HB.
“PSA Doubling Time Versus PSA Velocity to Predict High-Risk Prostate Cancer: Data from the Baltimore Longitudinal Study of Aging.”
European Urology, July 2008 (epub).
Link: http://www.ncbi.nlm.nih.gov/pubmed/18614274
Other Original Articles
Loeb S, Peskoe SB, Joshu CE, Huang WY, Hayes RB, Carter HB, Isaacs WB, Platz EA.
“Do Environmental Factors Modify the Genetic Risk of Prostate Cancer?”
Cancer Epidemiology Biomarkers Prevention 2015; 24: 213. PMID: 25342390.
Link: http://www.ncbi.nlm.nih.gov/pubmed/25342390
Other Original Articles
Martin NE, Chen MH, Catalona WJ, Loeb S, Roehl KA, and D’Amico AV.
“The Influence of Serial Prostate-Specific Antigen Screening on the PSA Velocity at Diagnosis.”
Cancer, 2008; 113: 717.
Link: http://www.ncbi.nlm.nih.gov/pubmed/18615505
Other Original Articles
Helfand BT, Loeb S, Hu Q, Cooper PR, Roehl KA, McGuire BB, Baumann NA, Catalona WJ.
“Personalized PSA Testing Using Genetic Variants May Reduce Unnecessary Biopsies.”
Journal of Urology 2012; epub December. PMID: 23246478.
Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3631301/
Other Original Articles
Carvalhal GF, Daudi SN, Kan D, Mondo D, Roehl KA, Loeb S, and Catalona WJ.
“Correlation Between Serum Prostate-Specific Antigen and Cancer Volume in Prostate Glands of Different Sizes.”
Urology, September 2010 epub.
Link: http://www.ncbi.nlm.nih.gov/pubmed/20846711
Other Original Articles
Loeb S, Kettermann A, Carter HB, Ferrucci L, Metter EJ, and Walsh PC.
“Does Prostate Growth Confound PSA Velocity: Data from the Baltimore Longitudinal Study of Aging.”
Journal of Urology, 2008; 180: 1314
Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2575041/
Other Original Articles
Reinhardt D, Helfand BT, Cooper PR, Roehl KA, Catalona WJ, and Loeb S.
“Prostate Cancer Risk Alleles are Associated with Prostate Cancer Tumor Volume and Prostate Size.”
Journal of Urology 2013; epub Dec 14. PMID: 24345439
Link: http://www.ncbi.nlm.nih.gov/pubmed/24345439
Other Original Articles
Meeks JJ, Thaxton CS, Loeb S, Roehl KA, Helfand BT, and Catalona WJ.
“Comparison of PSA Velocity of Screened Versus Referred Patients with Prostate Cancer.”
Journal of Urology 2008; 179: 1340.
Link: http://www.ncbi.nlm.nih.gov/pubmed/18289590
Other Original Articles
Loeb S, Carter HB, Walsh PC, Isaacs WB, Kettermann A, Tanaka T, Ferrucci L, and Metter EJ.
“Single Nucleotide Polymorphisms and the Likelihood of Prostate Cancer at a Given Prostate-Specific Antigen Level.”
Journal of Urology, July 2009; 182: 101.
Link: http://www.ncbi.nlm.nih.gov/pubmed/19450841
Other Original Articles
Eggener SE, Yossepowitch O, Roehl KA, Loeb S, Yu X, and Catalona WJ.
“The Relationship of PSA Velocity to Histologic Findings in a Prostate Cancer Screening Program.”
Urology 2008; 71: 1016.
Link: http://www.ncbi.nlm.nih.gov/pubmed/18358515
Other Original Articles
Loeb S, Carter HB, Schaeffer EM, Ferrucci L, Kettermann A, and Metter EM.
“Should Prostate-specific Antigen be Adjusted for Body Mass Index? Data From the Baltimore Longitudinal Study of Aging.”
Journal of Urology, December 2009; 182: 2646.
Link: http://www.ncbi.nlm.nih.gov/pubmed/19836806
Other Original Articles
Helfand BT, Hu Q, Loeb S, McVary KT, Catalona WJ.
“Genetic Sequence Variants are Associated with Severity of Lower Urinary Tract Symptoms and Prostate Cancer Susceptibility.”
Journal of Uroloy 2012 epub November. PMID: 23159463.
Link: http://www.ncbi.nlm.nih.gov/pubmed/23159463
Other Original Articles
Loeb S, Roehl KA, Yu X, Han M, and Catalona WJ.
“Use of PSAV to Follow Patients with Isolated High-Grade Prostatic Intraepithelial Neoplasia (HG-PIN) on Prostate Biopsy.”
Urology, January 2007; 69: 108.
Link: http://www.ncbi.nlm.nih.gov/pubmed/17270629
Other Original Articles
Meeks JJ, Loeb S, Helfand BT, Kan D, Smith ND, and Catalona WJ.
“Characteristics of Prostate Cancers Detected at Prostate-Specific Antigen Levels Less than 2.5 ng/ml.”
Journal of Urology, June 2009; 181: 2515.
Link: http://www.ncbi.nlm.nih.gov/pubmed/19371879
Other Original Articles
Cooper PR, McGuire BB, Helfand BT, Loeb S, Hu Q, and Catalona WJ.
“Prostate Cancer Risk Alleles and Their Associations with Other Malignancies.”
Urology October 2011; 78: 970 .e 15-20. PMID: 21820706.
Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3190015/
Other Original Articles
Loeb S, Roehl KA, Catalona WJ, and Nadler RB.
“PSA Velocity Threshold for Predicting Prostate Cancer in Young Men.”
Journal of Urology, March 2007; 177: 899.
Link: http://www.ncbi.nlm.nih.gov/pubmed/17296371
Other Original Articles
Loeb S, Chan DW, Sokoll L, Kan D, Mikolajczyk SD, Maggiore J, Mondo DM, Griffin CR, and Catalona WJ.
“PSA Standardization Bias Could Affect Clinical Decision-making.”
Journal of Urology, November 2008 (epub).
Link: http://www.ncbi.nlm.nih.gov/pubmed/18801532
Other Original Articles
Helfand BT, Fought AJ, Loeb S, Meeks JJ, Kan D, and Catalona WJ.
“Genetic prostate cancer risk assessment: common variants in 9 genomic regions are associated with cumulative risk.”
Journal of Urology, August 2010; 184: 501.
Link: http://www.ncbi.nlm.nih.gov/pubmed/20620408
Other Original Articles
Yu X, Loeb S, Han M, Suarez BK, Roehl KA, and Catalona WJ.
“The Association Between Total PSA and PSA Velocity.”
Journal of Urology, April 2007; 177: 1298.
Link: http://www.ncbi.nlm.nih.gov/pubmed/17382716
Other Original Articles
Okotie O, Roehl KA, Han M, Loeb S, Gashti SN, and Catalona WJ.
“Characteristics of Prostate Cancer Detected by Digital Rectal Examination Only.”
Urology December 2007; 70: 1117.
Link: http://www.ncbi.nlm.nih.gov/pubmed/18158030
Other Original Articles
Helfand BT, Loeb S, Kan D, Catalona WJ.
“Number of prostate cancer risk alleles may identify possibly ‘insignificant’ disease.”
BJU International, June 2010 epub.
Link: http://www.ncbi.nlm.nih.gov/pubmed/20590552
Other Original Articles
Loeb S, Yu X, Roehl KA, Nadler RB and Catalona WJ.
“PSA Velocity Thresholds in Men with Total PSA <4 ng/ml.”
Journal of Urology, December 2007; 178; 2348.
Link: http://www.ncbi.nlm.nih.gov/pubmed/17936844
Other Original Articles
Sotelo R, Mora K. E, Perez L. H, Novoa J, Castillo M, Carmona O, De Andrade R, Loeb S, and Catalona WJ.
“Assay Standardization Bias: Different Prostate Cancer Detection Rates and Clinical Outcomes Resulting From Different Assays for Free and Total Prostate-Specific Antigen (PSA).”
Urology, June 2007; 69: 1143.
Link: http://www.ncbi.nlm.nih.gov/pubmed/17572203
Other Original Articles
Loeb S, Roehl KA, Catalona WJ, and Nadler RB.
“Is the Utility of PSA Velocity for Prostate Cancer Detection Affected by Age?”
BJU International, April 2008; 101: 817.
Link: http://www.ncbi.nlm.nih.gov/pubmed/18321315
Other Original Articles
Roehl KA, Eggener SE, Loeb S, Smith ND, Antenor JAV, and Catalona WJ.
“Survival Results in Screen-Detected Prostate Cancer Patients Versus Physician-Referred Patients Treated With Radical Prostatectomy: Early Results.”
Urologic Oncology: Seminars and Original Investigations, November-December 2006; 24: 465.
Link: http://www.ncbi.nlm.nih.gov/pubmed/17138126
Other Original Articles
Loeb S, Helfand BT, Kan D, Isaacs WB, and Catalona WJ.
“Does Diabetes Mellitus Modify the Association between 17q12 Risk Variant and Prostate Cancer Aggressiveness?”
BJU International, November 2009; 104: 1200.
Link: http://www.ncbi.nlm.nih.gov/pubmed/19627283
Other Original Articles
Yu X, Han M, Loeb S, Gashti SN, Yeh JT, Roehl KA, and Catalona WJ.
“Comparison of Different Methods for Calculating PSA Velocity: Importance of Time Interval Prior to Diagnosis of Prostate Cancer.”
Journal of Urology, December 2006; 176: 2427.
Link: http://www.ncbi.nlm.nih.gov/pubmed/17085120
Other Original Articles
Loeb S, Gonzalez CM, Roehl KA, Han M, Antenor JV, Yap RL, and Catalona WJ.
“Pathologic Characteristics of Prostate Cancer Detected Through Prostate-Specific Antigen- Based Screening”
Journal of Urology, March 2006; 175: 902.
Link: http://www.ncbi.nlm.nih.gov/pubmed/16469576
Other Original Articles
Loeb S, Han M, Roehl KA, Antenor JV, and Catalona WJ.
“Accuracy of Prostate Weight Estimation by Digital Rectal Exam (DRE) Versus Transrectal Ultrasonography (TRUS).”
Journal of Urology, January 2005; 173: 63-5.
Link: http://www.ncbi.nlm.nih.gov/pubmed/15592029
Other Original Articles
Nadler RB, Loeb S, Roehl KA, Antenor JV, Eggener SE, and Catalona WJ.
“Use of 2.6 ng/ml Prostate Specific Antigen (PSA) Prompt for Biopsy for Men Over Age 60”
Journal of Urology, December 2005; 174: 2154.
Link: http://www.ncbi.nlm.nih.gov/pubmed/16280754
Other Original Articles
Donin N, Loeb S, Cooper PF, Roehl KA, Baumann NA, Catalona WJ, Helfand BT.
“Genetically-Adjusted PSA Values May Prevent Delayed Biopsies in African-American Men.”
BJU International 2014 Jan epub. PMID: 24712975
Link: http://www.ncbi.nlm.nih.gov/pubmed/24712975
Donin N, Loeb S, Cooper PF, Roehl KA, Baumann NA, Catalona WJ, Helfand BT.
“Genetically-Adjusted PSA Values May Prevent Delayed Biopsies in African-American Men.”
BJU International 2014 Jan epub.
PMID: 24712975
Link: http://www.ncbi.nlm.nih.gov/pubmed/24712975
Donin N, Loeb S, Cooper PF, Roehl KA, Baumann NA, Catalona WJ, Helfand BT.
“Genetically-Adjusted PSA Values May Prevent Delayed Biopsies in African-American Men.”
BJU International 2014 Jan epub.PMID: 24712975
Link: http://www.ncbi.nlm.nih.gov/pubmed/24712975
Other Original Articles
Lundstrom KJ, Drevin L, Carlsson S, Garmo H, Loeb S, Stattin P, Bill-Axelson A.
“Nationwide Population-Based Study of Infections After Transrectal Ultrasound Guided Prostate Biopsy.”
Journal of Urology 2014 May epub. PMID 24813343.
Link: http://www.ncbi.nlm.nih.gov/pubmed/24813343
Other Original Articles
Donin N, Loeb S, Cooper PF, Roehl KA, Baumann NA, Catalona WJ, Helfand BT.
“Genetically-Adjusted PSA Values May Prevent Delayed Biopsies in African-American Men.”
BJU International 2014 Jan epub. PMID: 24712975
Link: http://www.ncbi.nlm.nih.gov/pubmed/24712975
Other Original Articles
Grin B, Loeb S, Roehl K, Cooper PR, Catalona WJ, Helfand BT.
“A rare 8q24 single nucleotide polymorphism (SNP) predisposes North American men to prostate cancer and possibly more aggressive disease.”
BJU International 2014, June epub. PMID: 24952954.
Link: http://www.ncbi.nlm.nih.gov/pubmed/24952954
Other Original Articles
Loeb S, Carter HB, Berndt SI, Ricker W, Schaeffer EM.
“Is repeat prostate biopsy association with a greater risk of hospitalization? Data from SEER-Medicare.”
Journal of Urology epub Oct 9, 2012. PMID: 23063634.
Link: http://www.ncbi.nlm.nih.gov/pubmed/23063634
Loeb S.
“Germline Sequence Variants and Prostate Specific Antigen Interpretation.”
Clinical Chemistry May 2011; 57: 662-3. PMID: 21411622.
Link: http://www.ncbi.nlm.nih.gov/pubmed/21411622
Other Original Articles
Loeb S, Carter HB, Schaeffer EM, Ling SM, Kettermann A, Ferrucci L, and Metter EJ.
“Bone Mineral Content and Prostate Cancer Risk: Data from the Baltimore Longitudinal Study of Aging.”
BJU International, July 2010; 106: 28.
Link: http://www.ncbi.nlm.nih.gov/pubmed/20067459
Other Original Articles
Ross AE, Loeb S, Landis P, Partin AW, Epstein JI, Kettermann A, Feng Z, Carter HB, and Walsh PC.
“Prostate-specific antigen kinetics during follow-up are an unreliable trigger for intervention in a prostate cancer surveillance program.”
Journal of Clinical Oncology 2010; 28: 2810.
Link: http://www.ncbi.nlm.nih.gov/pubmed/20439642
Other Original Articles
Loeb S, Helfand BT, Kan D, Isaacs WB, and Catalona WJ.
“Does Diabetes Mellitus Modify the Association between 17q12 Risk Variant and Prostate Cancer Aggressiveness?”
BJU International, November 2009; 104: 1200.
Link: http://www.ncbi.nlm.nih.gov/pubmed/19627283
Helfand BT, Loeb S, Meeks JJ, Fought AJ, Kan D, and Catalona WJ.
“Pathological Outcomes Associated with the 17q Prostate Cancer Risk Variants.”
Journal of Urology, June 2009; 181: 2502.
Link: http://www.ncbi.nlm.nih.gov/pubmed/19371897
Other Original Articles
Loeb S, Kan D, Helfand BT, Gashti SN, Nadler RB, and Catalona WJ.
“Is Statin Use Associated with Prostate Cancer Aggressiveness?”
BJU International 2009, Nov 3 epub.
Link: http://www.ncbi.nlm.nih.gov/pubmed/19888973
Other Original Articles
Trock BJ, Guo CC, Gonzalgo ML, Magheli A, Loeb S, and Epstein JI.
“Impact of Tertiary Gleason Patterns on Biochemical Recurrence Following Radical Prostatectomy: Proposal for a Modified Gleason Scoring.”
Journal of Urology, August 2009 epub.
Link: http://www.ncbi.nlm.nih.gov/pubmed/19683280
Other Original Articles
Loeb S, Epstein JI, Humphreys EB, and Walsh PC.
“Does Perineural Invasion on Prostate Biopsy Predict Adverse Prostatectomy Outcomes?”
BJU International, August 2009 epub.
Link: http://www.ncbi.nlm.nih.gov/pubmed/19694710
Other Original Articles
Helfand BT, Loeb S, Meeks JJ, Fought AJ, Kan D, and Catalona WJ.
“Pathological Outcomes Associated with the 17q Prostate Cancer Risk Variants.”
Journal of Urology, June 2009; 181: 2502.
Link: http://www.ncbi.nlm.nih.gov/pubmed/19371897
Loeb S and Partin AW.
“Single Nucleotide Polymorphisms and Prostate Cancer Susceptibility.”
Reviews in Urology, Fall 2008; 10: 304.
Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2615108/
Helfand BT, Loeb S, Cashy J, Meeks JJ, Thaxton CS, Han M, and Catalona WJ.
“Tumor Characteristics of Carriers and Noncarriers of the deCODE 8q24 Prostate Cancer Susceptibility Alleles.”
Journal of Urology, June 2008; 179: 2197.
Link: http://www.ncbi.nlm.nih.gov/pubmed/18423739